- Report
- August 2024
- 175 Pages
Global
From €4722EUR$5,000USD£4,016GBP
- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
- Report
- April 2025
- 169 Pages
Global
From €5289EUR$5,600USD£4,498GBP
- Report
- March 2025
- 175 Pages
Global
From €4240EUR$4,490USD£3,607GBP
- Report
- February 2025
- 200 Pages
Global
From €4240EUR$4,490USD£3,607GBP
- Report
- February 2025
- 200 Pages
Global
From €4240EUR$4,490USD£3,607GBP
- Report
- February 2025
- 200 Pages
Global
From €4240EUR$4,490USD£3,607GBP
- Report
- March 2025
- 200 Pages
Global
From €4240EUR$4,490USD£3,607GBP
- Report
- February 2025
- 150 Pages
Global
From €4580EUR$4,850USD£3,896GBP
- Report
- July 2024
- 105 Pages
Global
From €4486EUR$4,750USD£3,815GBP
- Report
- August 2022
- 120 Pages
Global
From €4250EUR$4,500USD£3,615GBP
- Report
- March 2024
- 200 Pages
Global
From €3919EUR$4,150USD£3,334GBP
- Report
- November 2023
- 190 Pages
Global
From €4250EUR$4,500USD£3,615GBP
- Report
- March 2025
- 215 Pages
China
From €3778EUR$4,000USD£3,213GBP
- Report
- March 2025
- 109 Pages
China
From €1700EUR$1,800USD£1,446GBP

Lisinopril is a medication used to treat high blood pressure and other cardiovascular conditions. It belongs to a class of drugs known as angiotensin-converting enzyme (ACE) inhibitors, which work by blocking the action of certain hormones in the body that can cause blood vessels to narrow. This helps to reduce blood pressure and improve blood flow. Lisinopril is also used to treat congestive heart failure, and can be used in combination with other medications to reduce the risk of stroke and heart attack.
Lisinopril is available in both generic and brand-name forms, and is widely prescribed by doctors. It is generally well-tolerated, with few side effects. Common side effects include headache, dizziness, and fatigue.
The lisinopril market is a major component of the cardiovascular drugs market, which is estimated to be worth billions of dollars. It is expected to continue to grow in the coming years, driven by an aging population and increasing prevalence of cardiovascular diseases.
Some of the major companies in the lisinopril market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more